Ocular manifestations and complications in a cohort of Behçet’s disease patients in a tertiary hospital

[1]  Dina El-Fayoumi,et al.  Fundus fluorescein angiography and optical coherence tomography findings in ocular and non-ocular Behҫet’s disease , 2020 .

[2]  P. Ozdal.  Behçet's Uveitis: Current Diagnostic and Therapeutic Approach , 2020 .

[3]  A. El-Garf,et al.  Behçet’s disease patterns and subsets in a cohort of Egyptian patients , 2019, The Egyptian Rheumatologist.

[4]  M. Accorinti,et al.  Ocular Behçet’s Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis , 2017, Ocular immunology and inflammation.

[5]  J. Alió,et al.  Local (topical and intraocular) therapy for ocular Adamantiades−Behçet's disease , 2015, Current opinion in ophthalmology.

[6]  Amany R. El-Najjar,et al.  Clinical characteristics and disease activity of Behçet’s disease patients in Zagazig, Egypt , 2015 .

[7]  S. Ohno,et al.  A Major Review: Current Aspects of Ocular Behçet's Disease in Japan , 2015, Ocular immunology and inflammation.

[8]  J. F. Arevalo,et al.  Uveitis in Behçet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group. , 2015, American journal of ophthalmology.

[9]  H. Hussein,et al.  Serum tumor necrosis factor alpha (TNF-α) level in patients with Behçet’s disease: Relation to clinical manifestations and disease activity , 2014 .

[10]  I. Olivieri,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014 .

[11]  A. Allam,et al.  Serum homocysteine level and eye involvement in Egyptian patients with Behçet’s disease , 2014 .

[12]  J. Paović,et al.  Behcet's Disease: Systemic and Ocular Manifestations , 2013, BioMed research international.

[13]  T. Gheita,et al.  Serum level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity , 2013, Modern rheumatology.

[14]  F. Shahram,et al.  Behcet’s disease: is there a gender influence on clinical manifestations? , 2012, International journal of rheumatic diseases.

[15]  S. Gabriel,et al.  Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. , 2009, Arthritis and rheumatism.

[16]  J. Valente,et al.  Behçet's disease--a contemporary review. , 2009, Journal of autoimmunity.

[17]  Q. Meng,et al.  Clinical features of chinese patients with Behçet's disease. , 2008, Ophthalmology.

[18]  S. Yurdakul,et al.  Behçet's syndrome: disease manifestations, management, and advances in treatment , 2007, Nature Clinical Practice Rheumatology.

[19]  C. Evereklioglu,et al.  Current concepts in the etiology and treatment of Behçet disease. , 2005, Survey of ophthalmology.

[20]  H. Chng,et al.  Behcet's disease: experience in a tertiary rheumatology centre in Singapore and a review of the literature. , 2004, Annals of the Academy of Medicine, Singapore.

[21]  J. Hamburger,et al.  Behçet's syndrome: a multidisciplinary approach to clinical care. , 1999, QJM : monthly journal of the Association of Physicians.

[22]  S. Ohno,et al.  Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. , 1999, Tissue antigens.

[23]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.